| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.26 | 4e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 9e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |